Caffeic acid inhibits compound 48/80-induced allergic symptoms in mice

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 1, 2006, Pages 64-66

  Hossen, Maria Alejandra ^a   Inoue, Toshio ^a   Shinmei, Yoshifumi ^a   Minami, Kazuhisa ^a   Fujii, Yoko ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Caffeic acid; Compound 48 80; Scratching behavior; Vascular permeability

Indexed keywords

CAFFEIC ACID; COMPOUND 48-80;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EDEMA; FEMALE; MOUSE STRAIN; NONHUMAN; PRURITUS; SCRATCHING; SKIN ALLERGY;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CAFFEIC ACIDS; CAPILLARY PERMEABILITY; FEMALE; HISTAMINE RELEASE; HYPERSENSITIVITY; MICE; MICE, INBRED ICR; OXIDANTS; P-METHOXY-N-METHYLPHENETHYLAMINE; REGIONAL BLOOD FLOW; SKIN; SUPEROXIDES;

EID: 29844434427     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.64     Document Type: Article

References (25)

1. Booth A. N., Emerson O. H., Jones F. T., Deeds F., J. Biol. Chem., 229, 51-57 (1957).
2. Huang M. T., Smart R. C., Wong C. Q., Conney A. H., Cancer Res., 48, 5941-5946 (1988).
3. da Cunha F. M., Duma D., Assreuy J., Buzzi F. C., Niero R., Campos M. M., Calixto J. B., Free Radic. Res., 38, 1241-1253 (2004).
4. Bors W., Michel C., Stettmaier K., Lu Y., Foo L. Y., Biologic. Res., 37, 301-311 (2004).
5. Leung D. Y., Hanifin J. M., Charlesworth E. N., Li J. T., Bernstein I. L., Berger W. E., Blessing-Moore J., Fineman S., Lee R. E., Nicklas R. A., Spector S. L., Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Annals of Allergy, Asthma and Immunology, 79, 197-211 (1997).
6. Hägermark Ö., Hökfelt T., Pernow B., J. Invest. Dermatol., 71, 233-235 (1978).
7. Sugimoto Y., Umakoshi K., Nojiri N., Kamei C., Eur. J. Pharmacol., 351, 1-5 (1998).
8. Fukuishi N., Kan T., Hirose K., Akagi R., Akagi M., Jpn. J. Pharmacol., 68, 449-452 (1995).
9. Fukuishi N., Sakaguchi M., Matsuura S., Nakagawa C., Akagi R., Akagi M., Biochem. Mol. Med., 61, 107-113 (1997).
10. Yoshimaru T., Suzuki Y., Matsui T., Yamashita K., Ochiai T., Yamaki M., Shimizu K., Clin. Exp. Allergy, 32, 612-618 (2002).
11. Inagaki N., Igeta K., Kim J. F., Nagao M., Shiraishi N., Nakamura N., Nagai H., Eur. J. Pharmacol., 448, 175-183 (2002).
12. Siraganian R. P., Ann. Biochem., 57, 383-394 (1974).
13. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M., Eur. J. Pharmacol., 257, 229-233 (1995).
14. Nakayama Y., Mio M., Sugimoto Y., Fujii Y., Kamei C., Meth. Find. Exp. Clin. Pharmacol., 24, 267-273 (2002).
15. Shinomiya K., Omichi J., Ohnishi R., Ito H., Yoshida T., Kamei C., Eur. J. Pharmacol., 504, 185-189 (2004).
16. Clifford M. N., Proc. Biochem., 10, 13-16 (1975).
17. Uenishi T., Sugiura H., Uehara M., J. Dermatol., 30, 91-97 (2003).
18. Pagano R., Negri E., Decarli A., La Vecchia C., Chest, 94, 386-389 (1988).
19. Schwartz J., Weiss S. T., Ann. Epidemiol., 2, 627-635 (1992).
20. Fukuishi N., Takahashi H., Harada N., Kanoh R., Matsui N., Akagi M., Int. Arch. Allergy Immunol., 126, 140-146 (2001).
21. Kanoh R., Hatano T., Ito H., Yoshida T., Akagi M., Phytomedicine, 7, 297-302 (2000).
22. Saleem M., Kim H. J., Jin C., Lee Y. S., Arch. Pharm. Res., 27, 300-304 (2004).
23. Uang Y.-S., Hsu K.-Y., Biopharm. Drug Disposit., 18, 727-736 (1997).
24. Shinmei Y., Hossen M. A., Okihara K., Sugimoto H., Yamada H., Kamei C., Int. Immunopharmacol., 4, 1431-1436 (2004).
25. Ramos B. F., Zhang Y., Angkachatchai V., Jakschik B. A., J. Pharmacol. Exp. Ther., 262, 559-565 (1992).